“Access to high-quality human residual tissue is vital to truly advance animal-free innovation. VitalTissue plays a crucial role in this’’ states dr Jetty van Ginkel, Managing Director, hDMT
“At hDMT we facilitate and support the development of dynamic models derived from human tissues and organs, among others. These models enable us to better understand and treat diseases and to establish safety and efficacy of substances and medicines. In this way, we contribute to the development of innovative and biologically relevant models, including organoids and organ-on-chip models and to the transition towards animal-free innovation.”
“For the development of innovative human models, access to high-quality human residual tissue is crucial. Vitaltissue takes care of this. By professionally organizing their infrastructure, they offer researchers and entrepreneurs the tools to create innovative dynamic models to accelerate and improve the development of human-based tissue and organ models for effective patient treatment.”
